STORM-PE TRIAL

Update: 2025-11-19

Description

James Benenati, Robert Lookstein, and Rachel Rosovsky discuss the STORM-PE trial, the first-of-its-kind RCT for acute intermediate-high risk pulmonary embolism (PE).

Comments

In Channel

STORM-PE TRIAL

2025-11-1914:24

The EARLY TAVR and TAVR UNLOAD Trials

2025-11-1215:25

The EPIC-CAD Trial

2025-10-2914:27

The ECLIPSE Trial

2025-10-0107:38

The CLEAR SYNERGY (OASIS 9) Trial

2025-09-1707:45

The NOTION-3 Trial

2025-09-0317:21

TMVR in the Heart Failure Paradigm

2025-08-1514:12

The ABYSS Trial

2025-08-1306:02

Patient Selection and Treatment Goals

2025-08-1115:20

Women's Health Study: Biomarkers

2025-08-0609:51

Echocardiography and Quality Data

2025-08-0422:10

Insights on Intrepid 2-Yr Mitral TF EFS

2025-07-3016:01

New ESC Guidelines for AF

2025-07-2320:07

The STEEER-AF Trial

2025-07-0905:57

The EPIC-CAD Trial

2025-07-0212:08

Acute Coronary Care in Ethiopia

2025-06-1812:08

The POPular PAUSE TAVI Trial

2025-06-0404:47

The SENIOR-RITA Trial

2025-05-2110:10

The REDUCE-AMI Trial

2025-05-0712:50

The EARTH-STEMI Trial

2025-04-1606:16

00:00

#box-pro-ellipsis-176382583880081{-webkit-line-clamp:2;}STORM-PE TRIAL

STORM-PE TRIAL

TCTMD

STORM-PE TRIAL